Abstract:Bacteriophages have received recent attention for their therapeutic potential to treat antibiotic-resistant bacterial infections. One particular idea in phage therapy is to use phages that not only directly kill their bacterial hosts but also rely on particular bacterial receptors, such as proteins involved in virulence or antibiotic resistance. In such cases, the evolution of phage resistance would correspond to the loss of those receptors, an approach termed evolutionary steering. We previously found that during experimental evolution, phage U136B can exert selection pressure on Escherichia coli to lose or modify its receptor, the antibiotic efflux protein TolC, often resulting in reduced antibiotic resistance. However, for TolC-reliant phages like U136B to be used therapeutically, we also need to study their own evolutionary potential. Understanding phage evolution is critical for the development of improved phage therapies as well as the tracking of phage populations during infection. Here, we characterized phage U136B evolution in 10 replicate experimental populations. We quantified phage dynamics that resulted in five surviving phage populations at the end of the 10-day experiment. We found that phages from all five surviving populations had evolved higher rates of adsorption on either ancestral or coevolved E. coli hosts. Using whole-genome and whole-population sequencing, we established that these higher rates of adsorption were associated with parallel molecular evolution in phage tail protein genes. These findings will be useful in future studies to predict how key phage genotypes and phenotypes influence phage efficacy and survival despite the evolution of host resistance. IMPORTANCE Antibiotic resistance is a persistent problem in health care and a factor that may help maintain bacterial diversity in natural environments. Bacteriophages ("phages") are viruses that specifically infect bacteria. We previously discovered and characterized a phage called U136B, which infects bacteria through TolC. TolC is an antibiotic resistance protein that helps bacteria pump antibiotics out of the cell. Over short timescales, phage U136B can be used to evolutionarily "steer" bacterial populations to lose or modify the TolC protein, sometimes reducing antibiotic resistance. In this study, we investigate whether U136B itself evolves to better infect bacterial cells. We discovered that the phage can readily evolve specific mutations that increase its infection rate. This work will be useful for understanding how phages can be used to treat bacterial infections.

T7 phage-assisted evolution of riboswitches using error-prone replication and dual selection

Directed evolution of an orthogonal transcription engine for programmable gene expression in eukaryotes

Assessing the Orthogonality of Phage-Encoded RNA Polymerases for Tailored Synthetic Biology Applications in Pseudomonas Species

Directed Evolution of Replication-Competent Double-Stranded DNA Bacteriophage Toward New Host Specificity.

Programming CRISPRi-dCas9 to control the lifecycle of bacteriophage T7

Preparation And Crystallization Of Riboswitches

Bacteriophage T7 Transcription System: an Enabling Tool in Synthetic Biology.

Engineered Photoactivatable Genetic Switches Based on the Bacterium Phage T7 RNA Polymerase.

Targeted C-to-T and A-to-G Dual Mutagenesis System for RhtA Transporter in Vivo Evolution

Experimental Evolution of the TolC-Receptor Phage U136B Functionally Identifies a Tail Fiber Protein Involved in Adsorption through Strong Parallel Adaptation

T7 Phage Factor Required for Managing RpoS in Escherichia Coli

An efficient, scarless, selection-free technology for phage engineering

Advances in evolved T7 RNA polymerases for expanding the frontiers of enzymatic nucleic acid synthesis

An Orthogonal T7 Replisome for Continuous Hypermutation and Accelerated Evolution in E. coli

Riboswitching On Rna Virus Replication

An Orthogonal T7 Replisome for Continuous Hypermutation and Accelerated Evolution in

Repurposing an Endogenous CRISPR-Cas System to Generate and Study Subtle Mutations in Bacteriophages

Mapping the functional landscape of the receptor binding domain of T7 bacteriophage by deep mutational scanning

Integrating T7 RNA Polymerase and Its Cognate Transcriptional Units for a Host-Independent and Stable Expression System in Single Plasmid

In vivo evolutionary engineering of riboswitch with high-threshold for N-acetylneuraminic acid production.

Evolution of C‐Terminal Modification Tolerance in Full‐Length and Split T7 RNA Polymerase Biosensors